Authors
Mónica Pilar Ariza, Víctor Viñeta, Juan Manuel García-Lechuz
Published in
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
The exponential increase in multidrug-resistant organisms (MDROs) has been associated with higher patient mortality, prolonged mechanical ventilation, and extended ICU stays. Effective management of cross-transmission requires a shift from a reactive approach to a proactive epidemiological strategy based on active surveillance cultures, which detect up to 1.69 times more colonization events than passive methods. Screening should target specific anatomical sites: triple-site swabbing for methicillin-resistant Staphylococcus aureus (98% sensitivity, 100% negative predictive value); rectal sampling for vancomycin-resistant enterococci and carbapenem-resistant Enterobacterales; and respiratory tract monitoring for Gram-negative bacilli. Surveillance protocols should adhere to a structured timeline (at admission, weekly, and at discharge) and prioritize high-risk phenotypes while remaining adaptable to local epidemiology and emerging pathogens. The implementation of systematic active surveillance programs is highly cost-effective and is strongly recommended in high-risk settings such as ICUs and oncohematology units to optimize empirical antimicrobial therapy according to individual patient needs.
PMID:
43021619
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 11
- Comments 0